Lubner, S.J., Mahoney, M.R., Kolesar, J.L., Loconte, N.K., Kim, G.P., Pitot, H.C., Philip, P.A., Picus, J., Yong, W.P., Horvath, L., Van Hazel, G., Erlichman, C.E. and Holen, K.D. (2010) Report of a multicenter phase II trial testing a combination of biweekly bevacizumab and daily erlotinib in patients with unresectable biliary cancer: A phase II Consortium study. Journal of Clinical Oncology, 28, 3491-3497.